Skip to content
10-Q

Quarterly Report

Translate Bio, Inc.

0001193125-21-153243

← back to feed
Filed
May 6, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · May 3, 2021 75.23M sh
Shares Diluted Q1 2021 · Mar 31, 2021 79.1M sh
Shares Diluted Q1 2021 · Mar 31, 2020 60.01M sh
Capex Q1 2021 · Mar 31, 2021 $1.59M
Capex Q1 2021 · Mar 31, 2020 $2.33M
Operating Cash Flow Q1 2021 · Mar 31, 2021 $689K
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$31.45M
Short Term Investments Q1 2021 · Mar 31, 2021 $499.01M
Short Term Investments Q1 2021 · Dec 31, 2020 $312M
Cash And Equivalents Q1 2021 · Mar 31, 2021 $155.75M
Cash And Equivalents Q1 2021 · Dec 31, 2020 $342.03M
Cash And Equivalents Q1 2021 · Mar 31, 2020 $97.47M
Stockholders Equity Q1 2021 · Mar 31, 2021 $388.89M
Stockholders Equity Q1 2021 · Dec 31, 2020 $356.76M
Stockholders Equity Q1 2021 · Mar 31, 2020 $142.67M
Stockholders Equity Q1 2021 · Dec 31, 2019 $153.54M
Current Liabilities Q1 2021 · Mar 31, 2021 $118.02M
Current Liabilities Q1 2021 · Dec 31, 2020 $101.34M
Total Liabilities Q1 2021 · Mar 31, 2021 $501.75M
Total Liabilities Q1 2021 · Dec 31, 2020 $533.18M
Current Assets Q1 2021 · Mar 31, 2021 $699.54M
Current Assets Q1 2021 · Dec 31, 2020 $697.19M
Total Assets Q1 2021 · Mar 31, 2021 $890.64M
Total Assets Q1 2021 · Dec 31, 2020 $889.94M
Eps Diluted Q1 2021 · Mar 31, 2021 $0.34
Eps Diluted Q1 2021 · Mar 31, 2020 −$0.24
Eps Basic Q1 2021 · Mar 31, 2021 $0.35
Eps Basic Q1 2021 · Mar 31, 2020 −$0.24
Sga Expense Q1 2021 · Mar 31, 2021 $10.82M
Sga Expense Q1 2021 · Mar 31, 2020 $7.46M
Rd Expense Q1 2021 · Mar 31, 2021 $41.14M
Rd Expense Q1 2021 · Mar 31, 2020 $21.44M
Net Income Q1 2021 · Mar 31, 2021 $26.52M
Net Income Q1 2021 · Mar 31, 2020 −$14.28M
Operating Income Q1 2021 · Mar 31, 2021 $26.62M
Operating Income Q1 2021 · Mar 31, 2020 −$14.79M
Revenue Q1 2021 · Mar 31, 2021 $34.6M
Revenue Q1 2021 · Mar 31, 2020 $4.65M